We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Genetic Information Tripled from Newborn Blood Spot Screenings

By LabMedica International staff writers
Posted on 27 Jan 2011
Print article
A method that can yield more information from archived newborn blood has implications for diseases in infants and children and for population health studies.

Approximately 9000 activated genes were detected in samples from adult blood spots on Guthrie cards that had been archived anywhere from six months to three years. The modified method uses commercially available tools, it and can be easily adopted by scientists for use on newborn blood spots.

The new assay uses Agilent (Santa Clara, CA, USA) 4 × 44K microarrays for acquiring genome-wide gene expression profiles from blood spots on Guthrie cards. Due to the small amount of RNA obtained from each sample, major modifications, such as concentrating and amplifying the RNA and using a different labeling procedure, were performed.

Guthrie cards have been used for the past 20-30 years to collect blood for mandatory newborn screening programs in the United States, Australia, New Zealand, Japan, and most countries in Europe and South America. Blood is usually collected through a heel prick 24 to 48 hours after birth and is placed on the cards, which may be archived after screening.

Although genetic material in blood from Guthrie cards has been presumed to be degraded because of varying storage conditions, Van Andel Research Institute (VARI; Grand Rapids, MI, USA) scientists were able to detect more than 3,000 activated genes in each sample in a 2009 study. Using the new method, they were able to detect three times that amount.

"Genetic information from Guthrie cards is a valuable resource," said VARI distinguished scientific investigator Jim Resau, PhD. "It opens doors to examine risk factors and potentially diagnose diseases before the clinical features are present. One such disease might be cerebral palsy, which currently can't be diagnosed until a child is nearly two. The information could also be used to study pediatric cancers such as neuroblastoma, which is known to be present at birth in many cases." The study was published in the January 2011 edition of Pathology International.

Archived blood spots can be more than 20 years old; therefore, the next step is to investigate the power of activated gene detection in various archival periods. Prof. Resau said the cards could also be used for population studies, such as finding out when a particular virus first appeared in a specific region, or levels of compounds in that region that could be affecting public health.

Nigel Paneth, MD, M.P.H., university distinguished professor in the departments of epidemiology and pediatrics and human development at the Michigan State University College of Human Medicine (East Lansing, MI, USA) commented, "Showing that mRNA is reasonably well preserved in archived filter paper blood spots, whether frozen or not, opens up a very important avenue for clinical and translational research, especially in child health, because the largest such archive is samples used for newborn genetic screening."

Related Links:
Van Andel Research Institute
Michigan State University College of Human Medicine

New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Unit-Dose Packaging solution
HLX
New
Control Material
Blood Culture Identification Control Panel
New
Cooling Table Centrifuge
MPW-352R

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.